NCT02536846View on ClinicalTrials.gov

The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

November 8, 2019

Study Completion Date

November 8, 2019

Conditions
Healthy
Interventions
DRUG

Olanzapine

All subjects will take a single 2.5 mg dose of olanzapine (Zyprexa Zydis) followed by a 5 mg dose for 14 days. (2.5 mg/d for 1 day, 5 mg/d for 14 days).

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
lead

Dost Ongur

OTHER

NCT02536846 - The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals | Biotech Hunter | Biotech Hunter